TAZICEF
- Product NDC
- 0409-5082
- 11-digit product format
- 004095082
- Labeler code
- 0409
- Product ID
- 0409-5082_ab9c6f3a-f684-4cc3-b870-1a06a748a1a2
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- CEFTAZIDIME
- Dosage form
- INJECTION, POWDER, FOR SOLUTION
- Route
- INTRAMUSCULAR; INTRAVENOUS
- Labeler
- Hospira, Inc.
- Application
- ANDA062662
- Marketing category
- ANDA
- Marketing start
- 2005-11-02
- Substance
- CEFTAZIDIME
- Active strength
- 1 g/1
- Pharmacologic classes
- Cephalosporin Antibacterial [EPC], Cephalosporins [CS]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- TAZICEF
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| CEFTAZIDIME | 1 g/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 9M416Z9QNR |
| Rxcui | 1659283, 1659287, 1659292, 1659294 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 0409-5082-10 | TAZICEF | 10 in 1 CARTON | INJECTION, POWDER, FOR SOLUTION | 10 | | 16 |
| 0409-5082-11 | TAZICEF | 1 in 1 VIAL, SINGLE-DOSE | INJECTION, POWDER, FOR SOLUTION | 1 | | 16 |
| 0409-5082-16 | TAZICEF | 25 in 1 CARTON | INJECTION, POWDER, FOR SOLUTION | 25 | | 16 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| CEFTAZIDIME | ACTIVE INGREDIENT | 9M416Z9QNR | TAZICEF (CEFTAZIDIME) INJECTION, POWDER, FOR SOLUTION [HOSPIRA, INC.] | 2 | |
| CEFTAZIDIME ANHYDROUS | ACTIVE MOIETY | DZR1ENT301 | TAZICEF (CEFTAZIDIME) INJECTION, POWDER, FOR SOLUTION [HOSPIRA, INC.] | 2 | |
| Sodium Carbonate | INACTIVE INGREDIENT | 45P3261C7T | TAZICEF (CEFTAZIDIME) INJECTION, POWDER, FOR SOLUTION [HOSPIRA, INC.] | 2 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 0409-5082 | TAZICEF (CEFTAZIDIME) INJECTION, POWDER, FOR SOLUTION [HOSPIRA, INC.] | 15 | Current NDC, Legacy NDC, 3 package rows | 20240508_40d48c5d-650e-461b-a67b-7e65772d1b92.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0409-5082-10 | 00409508210 | 10 VIAL, SINGLE-DOSE in 1 CARTON (0409-5082-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (0409-5082-11) | 2026-05-05 | | No | No | Current |
| 0409-5082-11 | 00409508211 | 1 in 1 VIAL, SINGLE-DOSE | | | | | Historical |
| 0409-5082-16 | 00409508216 | 25 VIAL, SINGLE-DOSE in 1 CARTON (0409-5082-16) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (0409-5082-11) | 2005-11-02 | 0000-00-00 | No | No | Current |